Join the club for FREE to access the whole archive and other member benefits.


Company discovering breakthrough medicines that change the standard of medical care for patients

Celixir (formerly known as Cell Therapy Ltd.) is a private British regenerative medicine company that discovers and develops life-saving and life-altering regenerative medicines for patients with the greatest medical need. 

Celixir, founded in 2009, is made up of a world-class team of scientists and biopharmaceutical executives, led by Nobel Laureate Professor Sir Martin Evans and former Roche Global Head of Emerging Technologies, Ajan Reginald. 

Celixir’s unique platform technology allows us to adopt an ‘off-the-shelf’ approach to deliver regenerative medicines to patients.

Visit website:





Celixir is also referenced in the following:

Stephen Westaby

Chief Medical Advisor, Cardiac, Celixir

People at Celixir

Martin Evans

Co-founder, President and Chief Scientific Officer, Celixir

Celixir News

Update on successful dosing of first patient CLXR-001 by Celixir

GlobeNewswire - 06-Jul-2019

Ongoing clinical trials for heart patients with cellular therapy to cure damaged heart muscles